The prognostic significance of β human chorionic gonadotrophin and its metabolites in women with cervical carcinoma

Journal of Clinical Pathology

Volumn 51, Issue 9, 1998, Pages 685-688

  Crawford, Robin A F ^a,d   Iles, Ray K ^b   Carter, P G ^b   Caldwell, Carole J ^c   Shepherd, John H ^a   Chard, Tim ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Williamson Laboratory

^c Department of Pathology ^*

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cervical cancer; Immunohistochemistry; human chorionic gonadotrophin; core

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; CANCER; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT CANCER; UTERINE CERVIX CARCINOMA;

EID: 0031686260     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.9.685     Document Type: Article

References (18)

1. Campo K, Palacin A, Benasco C, et al. Human chorionic gonadotrophin in colorectal carcinoma; an immunohistochemical study. Cancer 1985;59:1611-16.
2. Iles RK, Jenkins BJ, Oliver RTD, et al. Beta human chononic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol 1989;64:241-4.
3. Sheaff MT, Martin JE, Badenoch DF, et al. β hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol 1996;49:329-32.
4. Cole LA, Tanaka A, Kim GS, et al. β-Core fragment (β-core/UGF/UGP), a tumor marker: a 7-year report. Gynecol Oncol 1996;60:264-70.
5. Carter PG, Iles RK, Neven P, et al. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance. Br J Cancer 1995;71:350-3.
6. Iles RK, Chard T. Human chorionic gonadotrophin expression by bladder cancers: biology and clinical potential as an indicator of poor prognosis. J Urol 1991;145:453-8.
7. Regelson W. Have we found the "definitive cancer" biomarker? Cancer 1995;76:1299-301.
8. Carpelan-Holmström M, Haglund C, Lundin J, et al. Independent prognostic value of pre-operative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br J Cancer 1996;74:925-9.
9. Moutzouris G, Yannopoulos D, Barbatis C, et al. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy? Br J Urol 1993;72: 907-9.
10. Wehmann RE, Blithe DL, Flack MR, et al. Metabolic clearance rate and urinary clearance of purified β-core. J Clin Endocrinol Metab 1989;69:510-17.
11. Carter PG, Iles RK, Neven P, et al. The prognostic significance of urinary βcore fragment in premenopausal women with carcinoma of the cervix. Gynecol Oncol 1994;55:271-6.
12. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994;173:371-9.
13. van Nagell JR, Rayburn WR, Donaldson ES, et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 1979;44:2354-61.
14. Look KY, Rocereto TF. Relapse patterns in FIGO stage 1B carcinoma of the cervix. Gynecol Oncol 1990;38:114-20.
15. Akar AH, Gervasi G, Blacker C, et al. Human chorionic gonadotrophin-like and β-core-like materials in postmenopausal urine. J Endocrinol 1990;125:477-84.
16. Iles RK, Lee CL, Howes I, et al. Immunoreactive β-core-like material in normal postmenopausal urine: human chorionic gonadotrophin or LH origin? Evidence for existence of LH core. J Endocrinol 1992;133:459-66.
17. Webb A, Scott-Mackie P, Cunningham D, et al. The prognostic value of CEA, beta hCG, AFP, CA 125, CA 19-9 and C-erb B-2, beta hCG immunohistochemistry in advanced colorectal cancer. Ann Oncol 1995;6:581-7.
18. Sasieni P, Cuzick J, Farmery E. Accelerated decline in cervical cancer mortality in England and Wales. Lancet 1995;346:1566-7.